Skip to content
  • Sunday, 26 July 2026
  • 3:21 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna Jun 20, 2026 0

A breakthrough in skeletal biology has emerged from the Institute of Science Tokyo, where researchers have identified a previously misunderstood…

Read More
Stem Cell & Regenerative Medicine

Stanford Medicine Researchers Discover Glucose Functions as a Master Regulator of Stem Cell Differentiation Beyond Energy Production

Dwi Wanna Jun 2, 2026 0

In a significant paradigm shift for the field of cell biology, researchers at Stanford Medicine have identified that glucose, the…

Read More
Stem Cell & Regenerative Medicine

Breakthrough Discovery of Fam102a Protein as Key Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna Jun 1, 2026 0

In a landmark study published in Nature Communications on January 2, 2025, a multidisciplinary team of researchers led by Professor…

Read More
Neuroscience & Brain Research

Brain Protein Menin Identified as Potential Master Regulator of Biological Aging and Cognitive Health

Rifan Muazin Jun 1, 2026 0

In a landmark study that may redefine the scientific understanding of how the body grows old, researchers have identified a…

Read More
Stem Cell & Regenerative Medicine

Duke-NUS Researchers Identify DEAF1 Protein as Key Regulator in Muscle Regeneration and Treatment for Sarcopenia and Cachexia

Dwi Wanna May 30, 2026 0

In an era defined by a rapidly aging global population, the medical community is facing an unprecedented rise in age-related…

Read More
Stem Cell & Regenerative Medicine

Stanford Medicine Study Reveals Glucose as a Master Regulator of Tissue Differentiation Beyond Its Role as Cellular Fuel

Dwi Wanna May 25, 2026 0

In a landmark study that challenges decades of biological dogma, researchers at Stanford Medicine have discovered that glucose, the primary…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna May 24, 2026 0

A breakthrough study led by researchers at the Institute of Science Tokyo has identified a critical protein, Fam102a (Family with…

Read More
Stem Cell & Regenerative Medicine

Stanford Medicine Researchers Identify Glucose as a Master Regulator of Tissue Differentiation Independent of Its Role as an Energy Source

Dwi Wanna May 18, 2026 0

The sugar glucose, long recognized as the primary fuel driving the machinery of almost every living cell, has been revealed…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna May 17, 2026 0

In a significant advancement for regenerative medicine and skeletal health, a team of researchers at the Institute of Science Tokyo…

Read More
Stem Cell & Regenerative Medicine

Salk Institute Researchers Identify BCL6 Protein as Key Regulator for Muscle Maintenance Amid GLP-1 Weight Loss Boom

Dwi Wanna May 16, 2026 0

The pharmaceutical landscape of the 21st century has been fundamentally altered by the rise of glucagon-like peptide-1 (GLP-1) receptor agonists.…

Read More

Posts pagination

1 2 3 … 5
Akeso Secures NMPA Approval for Gumokimab to Treat Plaque Psoriasis in ChinaMonash University and ClinChoice Forge Strategic Alliance to Accelerate Therapeutic Development and Enhance Patient Access to Novel TreatmentsNavigating the Quantum Frontier: Five Essential GitHub Repositories for Mastering Quantum Machine LearningBehavioral Clues in Midlife Fish Offer Powerful Predictions of Lifespan
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ